1-20 of 196
atherosclerosis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

Ana Devesa, Valentin Fuster, Ravi Vazirani, Inés García-Lunar, Belén Oliva, Samuel España, Andrea Moreno-Arciniegas, Javier Sanz, Cristina Perez-Herreras, Héctor Bueno, Enrique Lara-Pezzi, Ana García-Alvarez, Vicente Martínez de Vega, Leticia Fernández-Friera, Maria G. Trivieri, Antonio Fernández-Ortiz, Xavier Rossello, Javier Sanchez-Gonzalez, Borja Ibanez
Journal: Diabetes Care
Diabetes Care dc230871
https://doi.org/10.2337/dc23-0871
Published: 15 September 2023
View article titled, Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
Open the PDF for Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis in another window
Journal Articles

Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412–2421

José-Miguel González-Clemente, Gemma Llauradó, Albert Cano, Olga Giménez-Palop, Lara Albert, Joan Vendrell
Journal: Diabetes Care
Diabetes Care 2023;46(3):e85–e86
https://doi.org/10.2337/dc22-2344
Published: 22 February 2023
View article titled, Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412–2421
Open the PDF for Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412–2421 in another window
Journal Articles

Response to Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412–2421

Tonet Serés-Noriega, Laura Boswell, Verónica Perea, Antonio J. Amor
Journal: Diabetes Care
Diabetes Care 2023;46(3):e87–e88
https://doi.org/10.2337/dci22-0061
Published: 22 February 2023
View article titled, Response to Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412–2421
Open the PDF for Response to Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412–2421 in another window
Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Sandeep R. Das, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Mikhail Kosiborod, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S158–S190
https://doi.org/10.2337/dc23-S010
Published: 12 December 2022
View article titled, 10. Cardiovascular Disease and Risk Management: <em>Standards of Care in Diabetes—2023</em>
Open the PDF for 10. Cardiovascular Disease and Risk Management: <em>Standards of Care in Diabetes—2023</em> in another window
Journal Articles

Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184–1192

Cheng-Hsien Hung, Fu-Shun Yen, James Cheng-Chung Wei
Journal: Diabetes Care
Diabetes Care 2022;45(12):e181
https://doi.org/10.2337/dc22-0701
Published: 01 December 2022
View article titled, Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184–1192
Open the PDF for Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184–1192 in another window
Journal Articles

Response to Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184–1192

Yi-Sun Yang, Kai-Chieh Hu, Chia-Hung Kao
Journal: Diabetes Care
Diabetes Care 2022;45(12):e182–e183
https://doi.org/10.2337/dci22-0021
Published: 01 December 2022
View article titled, Response to Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184–1192
Open the PDF for Response to Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184–1192 in another window
Journal Articles

Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study

Jonas Brinck, Emil Hagström, Jonatan Nåtman, Stefan Franzén, Katarina Eeg-Olofsson, David Nathanson, Björn Eliasson
Journal: Diabetes Care
Diabetes Care 2022;45(12):3040–3049
https://doi.org/10.2337/dc22-1025
Published: 01 December 2022
View article titled, Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study
Open the PDF for Cardiovascular Outcomes in Patients With Both Diabetes and Phenotypic Familial Hypercholesterolemia: A Nationwide Register-Based Cohort Study in another window
Journal Articles

Sleep Duration and Risks of Incident Cardiovascular Disease and Mortality Among People With Type 2 Diabetes

Han Han, Ying Wang, Tongtong Li, Chengwu Feng, Catherine Kaliszewski, Yang Su, Yinfan Wu, Jian Zhou, Liang Wang, Geng Zong
Journal: Diabetes Care
Diabetes Care 2023;46(1):101–110
https://doi.org/10.2337/dc22-1127
Published: 16 November 2022
View article titled, Sleep Duration and Risks of Incident Cardiovascular Disease and Mortality Among People With Type 2 Diabetes
Open the PDF for Sleep Duration and Risks of Incident Cardiovascular Disease and Mortality Among People With Type 2 Diabetes in another window
Journal Articles

Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure

Sara J. Cromer, Julie C. Lauffenburger, Raisa Levin, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2023;46(1):65–74
https://doi.org/10.2337/dc22-0383
Published: 16 November 2022
View article titled, Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure
Open the PDF for Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure in another window
Journal Articles

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease

Julio A. Lamprea-Montealegre, Erin Madden, Sri Lekha Tummalapalli, Chi D. Chu, Carmen A. Peralta, Yuxian Du, Rakesh Singh, Sheldon X. Kong, Delphine S. Tuot, Michael G. Shlipak, Michelle M. Estrella
Journal: Diabetes Care
Diabetes Care 2022;45(12):2900–2906
https://doi.org/10.2337/dc22-0614
Published: 23 September 2022
View article titled, Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease
Open the PDF for Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease in another window
Journal Articles

Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis

Giulia Ferrannini, Linda G. Mellbin, Faith Kirabo, Chinthanie Ramasundarahettige, Hertzel C. Gerstein, Lars Rydén
Journal: Diabetes Care
Diabetes Care 2022;45(10):e146–e147
https://doi.org/10.2337/dc22-0903
Published: 30 August 2022
View article titled, Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis
Open the PDF for Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis in another window
Journal Articles

Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes

Tingting Geng, Yi Wang, Qi Lu, Yan-Bo Zhang, Jun-Xiang Chen, Yan-Feng Zhou, Zhenzhen Wan, Kunquan Guo, Kun Yang, Liegang Liu, Gang Liu, An Pan
Journal: Diabetes Care
Diabetes Care 2022;45(10):2422–2429
https://doi.org/10.2337/dc22-0717
Published: 19 August 2022
View article titled, Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes
Open the PDF for Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes in another window
Journal Articles

Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk

Tonet Serés-Noriega, Marga Giménez, Verónica Perea, Laura Boswell, Clara Viñals, Jesús Blanco, Irene Vinagre, Adriana Pané, Enric Esmatjes, Ignacio Conget, Antonio J. Amor
Journal: Diabetes Care
Diabetes Care 2022;45(10):2412–2421
https://doi.org/10.2337/dc22-0118
Published: 09 August 2022
View article titled, Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk
Open the PDF for Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk in another window
Journal Articles

National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001–2018

Shihchen Kuo, Chun-Ting Yang, William H. Herman, Lynda D. Lisabeth, Wen Ye
Journal: Diabetes Care
Diabetes Care 2022;45(9):2003–2011
https://doi.org/10.2337/dc21-2283
Published: 14 July 2022
View article titled, National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001–2018
Open the PDF for National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001–2018 in another window
Journal Articles

Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 Diabetes

Kamlesh Khunti, Vanita R. Aroda
Journal: Diabetes Care
Diabetes Care 2022;45(4):766–768
https://doi.org/10.2337/dci21-0064
Published: 29 March 2022
View article titled, Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 Diabetes
Open the PDF for Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 Diabetes in another window
Journal Articles

GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease

Yi-Sun Yang, Hsin-Hung Chen, Chien-Ning Huang, Chung Y. Hsu, Kai-Chieh Hu, Chia-Hung Kao
Journal: Diabetes Care
Diabetes Care 2022;45(5):1184–1192
https://doi.org/10.2337/dc21-1993
Published: 11 March 2022
View article titled, GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease
Open the PDF for GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease in another window
Journal Articles

Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes

Evangelos K. Oikonomou, Marc A. Suchard, Darren K. McGuire, Rohan Khera
Journal: Diabetes Care
Diabetes Care 2022;45(4):965–974
https://doi.org/10.2337/dc21-1765
Published: 04 February 2022
View article titled, Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes
Open the PDF for Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes in another window
Journal Articles

Socioeconomic Factors Play a More Important Role than Clinical Needs in the Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in People With Type 2 Diabetes

Hui Shao, Piaopiao Li, Jingchuan Guo, Vivian Fonseca, Lizheng Shi, Ping Zhang
Journal: Diabetes Care
Diabetes Care 2022;45(2):e32–e33
https://doi.org/10.2337/dc21-1800
Published: 17 January 2022
View article titled, Socioeconomic Factors Play a More Important Role than Clinical Needs in the Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in People With Type 2 Diabetes
Open the PDF for Socioeconomic Factors Play a More Important Role than Clinical Needs in the Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in People With Type 2 Diabetes in another window
Journal Articles

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

Dhruv Mahtta, David J. Ramsey, Michelle T. Lee, Liang Chen, Mahmoud Al Rifai, Julia M. Akeroyd, Elizabeth M. Vaughan, Michael E. Matheny, Karla Rodrigues do Espirito Santo, Sankar D. Navaneethan, Carl J. Lavie, Yochai Birnbaum, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani
Journal: Diabetes Care
Diabetes Care 2022;45(2):372–380
https://doi.org/10.2337/dc21-1815
Published: 17 January 2022
View article titled, Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs
Open the PDF for Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs in another window
Journal Articles

Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013–2018

Mohamad B. Taha, Javier Valero-Elizondo, Tamer Yahya, César Caraballo, Rohan Khera, Kershaw V. Patel, Hyeon Ju R. Ali, Garima Sharma, Elias Mossialos, Miguel Cainzos-Achirica, Khurram Nasir
Journal: Diabetes Care
Diabetes Care 2022;45(3):594–603
https://doi.org/10.2337/dc21-1757
Published: 11 January 2022
View article titled, Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013–2018
Open the PDF for Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013–2018 in another window